1466 — Baijin Life Science Holdings Share News
0.000.00%
- HK$1.54bn
- HK$1.54bn
- HK$89.30m
Brief: Baijin Life Science Says Unit Enters Strategic Cooperation Framework Agreement With Foryoung Biotechnology
Brief: Baijin Life Science Says Unit To Invest In Guhuan Medical For Sales Channel
Brief: Baijin Life Science Expects Net Profit Of HK$2.5 Million For HY
Brief: Baijin Life Science Says Beijing Baijin To Invest In Youhuan Bio For Circrna Platform
Brief: Baijin Life Science Enters Subscription Agreements For Aggregate Of 40 Million Shares At HK$0.48 Per Share
Brief: Baijin Life Science Applies To Stock Exchange To Resume Trading
Brief: Baijin Life Science Announces Issuance Of 65.4 Million Subscription Shares
Brief: Affluent Partners's Unit Entered Into Agreement With Taihe Huamei (Zhejiang) Medical Technology Company
Brief: Affluent Partners Says Unit Entered Into A Strategic Cooperation Framework Agreement
Brief: Affluent Partners Subscribes Aggregate Of 27.8 Million Shares
Brief: Affluent Partners Says Application Has Been Made To Stock Exchange To Resume Trading
Brief: Affluent Partners Sees Loss Of HK$8.4 Mln For Year
Brief: Affluent Partners Says Su Yaoyao Has Been Appointed As An Executive Director
Brief: Affluent Partners Holdings Says Expects HY Loss Of About HK$2 Million Attributable
Brief: Affluent Partners Says Dong Peng Appointed As Executive Director
Brief: Affluent Partners Says Acquisition Of Entire Equity Interest In Tonnett Julis
Brief: Affluent Partners Sees Net Profit Of HK$8.7 Million Attributable For Year
Competition and Mkts - IVC/multiple independent veterinary businesses
Brief: Affluent Partners Sees Net Profit Of HK$10.3 Million For Six Months